VISIPAQUE
As listed in the register: VISIPAQUE 320 mg d'I/mL, solution injectable
65,200 g · solution injectable
- Prescription only
- Active substance
- Iodixanol
- Made by
- GE HEALTHCARE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Visipaque). It describes the substance, not this exact product.
Intravascular injection of iodixanol opacifies vessels in the path of flow of the contrast agent, permitting visualization of internal structures.
In imaging of the body, iodinated contrast agents diffuse from the vascular into the extravascular space.
In adults, approximately 97% of the injected dose of iodixanol is excreted unchanged in urine within 24 hours, with less than 2% excreted in feces within five days post-injection.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-10-17
Safety of the active substance
From the US prescribing label for the same active substance (Visipaque). It describes the substance, not this exact product.
WARNING: NOT FOR INTRATHECAL USE Inadvertent intrathecal administration may cause death, convulsions/seizures, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, rhabdomyolysis, hyperthermia, and brain edema [see Contraindications (4) and Warnings and Precautions (5.1) ].
- Intrathecal use [see Warnings and Precautions (5.1) ].
- Not indicated for intrathecal use.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | GE HEALTHCARE |
|---|---|
| Active substance | Iodixanol |
| Strength | 65,200 g |
| Form | solution injectable |
| Route | intraartérielle;intrathécale;intraveineuse;orale;rectale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | VISIPAQUE 320 mg d'I/mL, solution injectable |
| Packs | 1 bouteille(s) polypropylène de 100 ml avec seringue(s) pour injecteur Nemoto (+ microperfuseur + raccord) et avec cathéter(s) · 1 bouteille(s) polypropylène de 100 ml avec seringue(s) pour injecteur Medrad Stellant (+ microperfuseur + raccord) et avec cathéter(s) · 1 bouteille(s) polypropylène de 150 ml avec seringue(s) pour injecteur Nemoto (+ microperfuseur + raccord) et avec cathéter(s) · 1 bouteille(s) polypropylène de 150 ml avec seringue(s) pour injecteur Medrad Stellant (+ microperfuseur + raccord) et avec cathéter(s) · 1 flacon(s) polypropylène de 150 ml avec tubulure patient pour injecteur Ulrich CT motion et avec cathéter(s) · 1 flacon(s) polypropylène de 100 ml avec tubulure patient pour injecteur Ulrich CT motion et avec cathéter(s) · 10 bouteille(s) polypropylène de 500 ml · 1 flacon(s) en verre de 20 ml · 1 flacon(s) polypropylène de 50 ml · 10 flacon(s) polypropylène de 50 ml · 1 bouteille(s) polypropylène de 100 ml · 10 bouteille(s) polypropylène de 100 ml · 1 bouteille(s) polypropylène de 150 ml · 1 bouteille(s) polypropylène de 200 ml · 10 bouteille(s) polypropylène de 200 ml · 10 flacon(s) en verre de 20 ml |
| CIS | 60567418 |
| CIP13 | 3400926677770 |
| CIP13 | 3400926677831 |
| CIP13 | 3400926678081 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution injectable2 products
- 55 g
- 65,200 g
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.